Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $48.15 and last traded at $48.15, with a volume of 0 shares changing hands. The stock had previously closed at $48.15.
Basilea Pharmaceutica Stock Performance
The business’s fifty day moving average price is $46.60 and its 200-day moving average price is $42.83.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Featured Articles
- Five stocks we like better than Basilea Pharmaceutica
- Retail Stocks Investing, Explained
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- What Is WallStreetBets and What Stocks Are They Targeting?
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
